Lifeward (NASDAQ:LFWD) Stock Price Down 2.8% – Should You Sell?

Lifeward Ltd. (NASDAQ:LFWD) was down 2.8% during mid-day trading on Friday . The stock traded as low as $0.67 and last traded at $0.6706. Approximately 256,543 shares changed hands during mid-day trading, a decline of 35% from the average daily volume of 396,353 shares. The stock had previously closed at $0.6898.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on LFWD shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Lifeward in a research note on Wednesday, October 8th. HC Wainwright reduced their price objective on Lifeward from $13.00 to $4.50 and set a “buy” rating for the company in a report on Tuesday, November 18th. Three analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $6.17.

Lifeward Stock Performance

The firm has a fifty day moving average of $0.64 and a 200-day moving average of $0.66. The stock has a market capitalization of $12.27 million and a price-to-earnings ratio of -0.23.

Lifeward (NASDAQ:LFWD) last announced its earnings results on Friday, November 14th. The company reported ($0.20) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.06). The business had revenue of $6.20 million for the quarter, compared to analyst estimates of $6.31 million. Lifeward had a negative net margin of 121.82% and a negative return on equity of 183.18%. On average, analysts predict that Lifeward Ltd. will post -1.78 EPS for the current year.

Institutional Investors Weigh In On Lifeward

A hedge fund recently raised its stake in Lifeward stock. Citadel Advisors LLC boosted its stake in Lifeward Ltd. (NASDAQ:LFWD) by 1,271.8% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 214,006 shares of the company’s stock after buying an additional 198,406 shares during the period. Citadel Advisors LLC owned 1.36% of Lifeward worth $152,000 at the end of the most recent quarter. 26.76% of the stock is currently owned by institutional investors and hedge funds.

Lifeward Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.